Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe webpage has updated its version from v2.16.1 to v2.16.2 and has removed several past dates from December 2024 while adding new dates in May 2025.SummaryDifference0.7%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check77 days agoChange DetectedThe webpage has been updated to reflect a new version of a clinical trial study, including changes in the principal investigator's name and the addition of collaborators. Key details about the study's objectives and inclusion criteria have been removed, which may affect the clarity of the trial's purpose and participant requirements.SummaryDifference54%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.